Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,176.50p
   
  • Change Today:
      7.00p
  • 52 Week High: 1,371.50p
  • 52 Week Low: 982.40p
  • Currency: UK Pounds
  • Shares Issued: 837.43m
  • Volume: 2,745,390
  • Market Cap: £9,852m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.5% 0.0%
Div Cover 2.6 2.9
Op Mrgn 12.9% 17.4%
ROCE 16.4%  
Latest F'cast
P/E 15.2 15.7
PEG 0.7 1.2
Pr/Revenue 2.1 1.8
Pr/Book 2.5  
Latest F'cast
Revenue 6.1% -21.0%
PBT 56.4% 8.8%
EPS 21.0% -17.4%
DPS 4.3% -43.0%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 5,212.00 586.00 80.90¢ 21.1 0.8 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 17.9 17.9 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 17.2 17.2 +1% 37.50¢ 2.6%
31-Dec-24 5,810.00 498.00 84.30¢ 15.5 7.8 +2% 37.50¢ 2.9%
31-Dec-25 6,164.00 779.00 102.00¢ 16.0 0.8 +21% 39.10¢ 2.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 6,437.28 1,119.55 84.27p 14.0 n/a -17% 29.44p 0.0%
31-Dec-27 6,749.01 1,213.03 91.27p 12.9 1.6 +8% 31.11p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

No recent information was found.

Smith and Nephew ShareCast News

Smith & Nephew cuts annual guidance as US orthop... 04-Nov-2026 ShareCast
Smith & Nephew CFO John Rogers to step down 19-Aug-2026 ShareCast
Smith & Nephew lifts H1 profits, lowers FY reven... 04-Aug-2026 ShareCast

Smith and Nephew Top Newspaper Links

Smith & Nephew open to deal for its orthopaedics... 04-Nov-2026 Times
Smith & Nephew finance chief abruptly quits for ... 19-Aug-2026 Times
Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
06-Nov-26 Buy Dividends Deepak Nath 1,167.67p 4,355 £50,851.02

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,176.50p
Change Today 7.00p
% Change 0.60 %
52 Week High 1,371.50p
52 Week Low 982.40p
Volume 2,745,390
Shares Issued 837.43m
Market Cap £9,852m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.95% below the market average82.95% below the market average82.95% below the market average82.95% below the market average82.95% below the market average
92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average
Price Trend
18.23% above the market average18.23% above the market average18.23% above the market average18.23% above the market average18.23% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average
Income
44.53% below the market average44.53% below the market average44.53% below the market average44.53% below the market average44.53% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
68.16% above the market average68.16% above the market average68.16% above the market average68.16% above the market average68.16% above the market average
25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 11
Sell 2
Strong Sell 0
Total 16
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 01-Oct-26 26-Mar-26
Paid 06-Nov-26 27-May-26
Amount 15.60¢ 24.10¢

Trades for 13-Nov-2026

Time Volume / Share Price
16:35 1,218,985 @ 1,176.50p
16:35 3,703 @ 1,176.50p
16:35 2,835 @ 1,176.50p
16:35 600 @ 1,176.50p
16:35 600 @ 1,176.50p

Smith and Nephew Key Personnel

CEO Deepak Nath

Top of Page